Registered entities
HANSA BIOPHARMA AB
Reg. No. 925873667Norway
HANSA BIO
Reg. No. 40103899653Latvia
HANSA SALES
Reg. No. 40103812575Latvia
Innovation
16 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 624 times.
| Year | Filings |
|---|---|
| 2013 | 2 |
| 2017 | 3 |
| 2020 | 7 |
| 2021 | 8 |
| 2022 | 9 |
| 2023 | 10 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 5 |
Social engagement
Social engagement: 14K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Private equity | 2 | 67% |
Recent activity
19 Jun 2026
Event
American Transplant Congress (ATC)
15 Jun 2026
Leadership hire
Chief Financial Officer (CFO)
12 Jun 2026
Event
Capital Markets Day